Results 151 to 160 of about 4,278 (207)

Fibrinolysin Therapy

Archives of Surgery, 1961
Introduction Recent advances in the production of potent fibrinolytic materials of human origin 1 have resulted in their increasing administration to patients with thromboembolic disorders. The doses of these materials which have been recommended have been somewhat arbitrary, since they are based on clinical trials under circumstances where the ...
H, OUCHI, J S, BELKO, R, WARREN
openaire   +2 more sources

Lability of Fibrinolysin

Nature, 1959
FEARNLEY'S method for estimating fibrinolytic activity of normal blood1 is based on the fact that the clot formed by adding thrombin to blood diluted 1 : 10 with phosphate buffer will lyse on incubation. This lytic activity may be lost if the specimen is permitted to stand for hours or even minutes at room temperature.
openaire   +2 more sources

Fibrinolysins from Fibrin Clots

Nature, 1964
THREE fibrinolytic agents have been encountered in fibrin clots. The first was described as lytic factor in an earlier communication1. It was extracted with borate from trypsin-digested clots. It has since been found that extraction can be carried out successfully with 0.9 per cent sodium chloride and other salt solutions. Active preparations contained
openaire   +2 more sources

Influence of Fibrinolysin on Shock

JAMA, 1963
THE COMMON DENOMINATOR of all types of reversible shock appears to be an inadequate perfusion of vital visceral capillaries. This is affected, but not exclusively determined, by arterial blood pressure, cardiac output and venous return to the heart, vasoconstriction or dilitation, blood volume, heart failure, and other factors.
R M, HARDAWAY, D G, JOHNSON
openaire   +2 more sources

TREATMENT OF THROMBOSIS WITH FIBRINOLYSIN (PLASMIN)

Journal of the American Medical Association, 1958
The possibility of dissolving a recent thrombus by the intravenous administration of a fibrinolytic enzyme was studied in a series of patients. Fibrinolysin (plasmin) was prepared in several ways from human and bovine plasma, and preparations were obtained from other laboratories also. Altogether 114 infusions of fibrinolysin were given to 37 volunteer
J E, SOKAL, J L, AMBRUS, C M, AMBRUS
openaire   +2 more sources

USE OF FIBRINOLYSIN IN SURGICAL COMPLICATIONS

Archives of Surgery, 1952
WE ARE presenting our experience with the enzymatic agent fibrinolysin in the treatment of several surgical complications. One hundred instances in which the material was used are reviewed in order to evaluate its worth. The proenzyme, profibrinolysin, occurs naturally and circulates in human and animal plasma.
R R, MARGULIS, B E, BRUSH
openaire   +2 more sources

Fibrinolysin.

Memphis and Mid-South medical journal, 2020
K. Moser
semanticscholar   +1 more source

INTRAVENOUS FIBRINOLYSIN THERAPY

Journal of the American Medical Association, 1959
To the Editor:— InThe Journal, June 27, page 101, Dr. Paul W. Boyles reported a severe systemic reaction to intravenous fibrinolysin therapy, with high fever, hypertension, angioneurotic edema, and mental confusion. While patients I have treated with the preparation that he used have shown some febrile reactions and while it is hoped that a more ...
openaire   +1 more source

Prothrombin and Fibrinolysin

Science, 1946
W H, SEEGERS, E C, LOOMIS
openaire   +3 more sources

Thrombolysis with fibrinolysin in cerebral arterial occlusion.

Journal of the American Medical Association, 1958
B. J. Sussman, T. S. Fitch
semanticscholar   +1 more source